Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $10.15 Average Price Target from Analysts

Key Points

• Analysts have given Walgreens Boots Alliance an average recommendation of "Reduce", with four sell ratings, six holds, and one buy recommendation.
• The company's stock price target among brokerages is $10.15, and it recently opened at $11.98, well below its twelve-month high of $13.25.
• Walgreens Boots Alliance reported earnings of $0.38 per share, exceeding estimates, and saw a 7.2% year-over-year revenue increase to $38.99 billion.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) have been assigned a consensus rating of "Reduce" from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $10.15.

A number of research firms have recently issued reports on WBA. Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen began coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in WBA. Townsquare Capital LLC increased its stake in shares of Walgreens Boots Alliance by 2.3% during the first quarter. Townsquare Capital LLC now owns 44,104 shares of the pharmacy operator's stock worth $493,000 after purchasing an additional 996 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in shares of Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after acquiring an additional 1,000 shares during the last quarter. MAI Capital Management lifted its holdings in shares of Walgreens Boots Alliance by 1.9% in the 1st quarter. MAI Capital Management now owns 57,827 shares of the pharmacy operator's stock worth $646,000 after acquiring an additional 1,055 shares during the last quarter. Frank Rimerman Advisors LLC increased its stake in Walgreens Boots Alliance by 6.6% during the 1st quarter. Frank Rimerman Advisors LLC now owns 17,682 shares of the pharmacy operator's stock worth $198,000 after buying an additional 1,094 shares during the period. Finally, Independent Advisor Alliance increased its position in shares of Walgreens Boots Alliance by 3.0% in the 1st quarter. Independent Advisor Alliance now owns 39,978 shares of the pharmacy operator's stock valued at $447,000 after purchasing an additional 1,150 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA remained flat at $11.98 during mid-day trading on Wednesday. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $13.25. The firm has a market cap of $10.37 billion, a P/E ratio of -1.64, a P/E/G ratio of 1.42 and a beta of 0.80. The company's 50-day moving average price is $11.74 and its two-hundred day moving average price is $11.31.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm's revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.63 EPS. As a group, equities analysts anticipate that Walgreens Boots Alliance will post 1.6 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.